| Market Cap | ₹3,561Cr |
| ROE | 13.56% |
| P/E Ratio(TTM) | 17.90 |
| EPS(TTM) | 21.80 |
| P/B Ratio | 2.43 |
| Dividend Yield | 0.26% |
| Industry P/E | 32.95 |
| Book Value | 160.87 |
| Debt to Equity | 0.39 |
| Face Value | 10 |
| Parent Organisation | Aarti Drugs Limited |
| Managing Director | Shri Prakash M. Patil |
| Founded | 1984 |
| NSE Symbol | AARTIDRUGS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 67.22 | ||
| Neuland Laboratories | NA (0.00%) | 87.06 | ||
| Jubilant Pharmova | NA (0.00%) | 35.59 | ||
| Acutaas Chemicals | NA (0.00%) | 61.09 |